贵州医药
貴州醫藥
귀주의약
GUIZHOU MEDICAL JOURNAL
2013年
11期
963-966
,共4页
血小板膜糖蛋白Ⅱb%急性冠脉综合征%基因多态性%经皮冠状动脉介入治疗%血小板活性
血小闆膜糖蛋白Ⅱb%急性冠脈綜閤徵%基因多態性%經皮冠狀動脈介入治療%血小闆活性
혈소판막당단백Ⅱb%급성관맥종합정%기인다태성%경피관상동맥개입치료%혈소판활성
Platelet membrane glycoprotein Iib%Acute coronary syndrome Polymorphism%Percutaneous coronary intervention%Platelet function
目的:探讨血小板膜糖蛋白(GP)Ⅱb HPA-3基因多态性与急性冠脉综合征(ACS)经皮冠状动脉介入治疗(PCI)前后血小板功能变化的关系。方法选择行 PCI的ACS患者120例测定GPⅡb HPA-3基因型,测定各基因型 PCI术前、术后即刻、术后24 h三个时间段血浆GMP-140、vWF和PAI-1浓度。对不同基因型PCI前后血小板功能指标进行对比。结果经Logistic回归分析校正各因素后发现:GPⅡbHPA-3 bb基因型是心肌梗死的独立危险因素。GMP-140在bb基因型组PCI术后即刻、术后24 h较aa、ab基因型均增高(P<0.01)。vWF三种基因组差异无统计学意义。PAI-1 bb在基因组PCI术后即刻比aa、ab基因型存在更明显的PAI-1活化(P<0.01)。结论血小板GPⅡb HPA-3bb基因型可能是心肌梗死的独立危险因素,并且该基因型ACS患者在 PCI术后存在更迅速、更显著的血小板活化,提示bb基因型可能是PCI后血栓负荷过重和术后心血管事件的危险因素。
目的:探討血小闆膜糖蛋白(GP)Ⅱb HPA-3基因多態性與急性冠脈綜閤徵(ACS)經皮冠狀動脈介入治療(PCI)前後血小闆功能變化的關繫。方法選擇行 PCI的ACS患者120例測定GPⅡb HPA-3基因型,測定各基因型 PCI術前、術後即刻、術後24 h三箇時間段血漿GMP-140、vWF和PAI-1濃度。對不同基因型PCI前後血小闆功能指標進行對比。結果經Logistic迴歸分析校正各因素後髮現:GPⅡbHPA-3 bb基因型是心肌梗死的獨立危險因素。GMP-140在bb基因型組PCI術後即刻、術後24 h較aa、ab基因型均增高(P<0.01)。vWF三種基因組差異無統計學意義。PAI-1 bb在基因組PCI術後即刻比aa、ab基因型存在更明顯的PAI-1活化(P<0.01)。結論血小闆GPⅡb HPA-3bb基因型可能是心肌梗死的獨立危險因素,併且該基因型ACS患者在 PCI術後存在更迅速、更顯著的血小闆活化,提示bb基因型可能是PCI後血栓負荷過重和術後心血管事件的危險因素。
목적:탐토혈소판막당단백(GP)Ⅱb HPA-3기인다태성여급성관맥종합정(ACS)경피관상동맥개입치료(PCI)전후혈소판공능변화적관계。방법선택행 PCI적ACS환자120례측정GPⅡb HPA-3기인형,측정각기인형 PCI술전、술후즉각、술후24 h삼개시간단혈장GMP-140、vWF화PAI-1농도。대불동기인형PCI전후혈소판공능지표진행대비。결과경Logistic회귀분석교정각인소후발현:GPⅡbHPA-3 bb기인형시심기경사적독립위험인소。GMP-140재bb기인형조PCI술후즉각、술후24 h교aa、ab기인형균증고(P<0.01)。vWF삼충기인조차이무통계학의의。PAI-1 bb재기인조PCI술후즉각비aa、ab기인형존재경명현적PAI-1활화(P<0.01)。결론혈소판GPⅡb HPA-3bb기인형가능시심기경사적독립위험인소,병차해기인형ACS환자재 PCI술후존재경신속、경현저적혈소판활화,제시bb기인형가능시PCI후혈전부하과중화술후심혈관사건적위험인소。
Objective To investigate the possible relationship between platelet membrane glyco-protein (GP) IIb HPA-3gene polymorphism and changes of platelet function and the fibrinolytic activi-ty in patients with acute coronary syndrome (ACS ) ,undergoing percutaneous coronary intervention (PCI) .Methods 120 patients ,who were definitely diagnosed with ACS in the Affiliated Hospital of Guiyang Medical College ,were chosen to check platelet GP IIb HPA-3 gene polymorphism by polymer-ase chain reaction-sequence specific primers (PCR-SSP ) .Before and after PCI immediately ,and 24 hours after PCI ,the plasma GMP-140 ,vWF and PAI-1 levels were determined to analysis the change of platelet function indicators in patients with different genotype .Results The Logistic regression analysis found that GP Ⅱ bHPA -3 bb genotype is a independent risk factor for acute myocardial infarction (AMI) after correction factors .The plasma GMP-140 level in the bb genotype group was remarkably increased immediately and 24 hours after PCI among the three genotypes (P< 0 .01) .The plasma vWF level no statistical difference appeared among the three genotypes .The plasma PAI-1 level imme-diately after PCI ,there were statistical significantly differences between the bb genotype and the others (P<0 .01) .Conclusion The HPA-3 polymorphism of GP IIb is the risk factor of AMI .There is re-markable platelet activation and the fibrinolytic activity changes in patients with GP HPA-3bb geno-type than in those without it after PCI .The results are suggested that the bb genotype of platelet GP IIb HPA-3 maybe a dangerous factor in acute and sub-acute coronary thrombosis after PCI .